Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | ACC

March 20, 2018 — Among people younger than 75 years who were given clot busters to treat a heart attack, taking the more ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — When patients who had a heart attack were given vouchers to cover their co-payments for medication to ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — Patients with acute coronary syndrome experienced a substantially lower rate of heart attack, stroke ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — A pill combining low doses of three blood pressure-lowering medications significantly increased the ...

Home March 20, 2018
Home
News | ACC

March 20, 2018 — African-American men who received medical intervention aimed at controlling their high blood pressure w ...

Home March 20, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

March 19, 2018 — The combined rate of death from any cause, heart attack or stroke within 18 months was not ...

Home March 19, 2018
Home
News | ACC

March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to ...

Home March 15, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...

Home March 14, 2018
Home
News | Cardio-oncology

March 14, 2018 — After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker ...

Home March 14, 2018
Home
News | Cardio-oncology

March 14, 2018 — Breast cancer patients who started taking one of two well-known heart medications at the same time they ...

Home March 14, 2018
Home
News | ACC

March 13, 2018 –  Among patients with persistently high cholesterol despite high-intensity statin therapy, the ...

Home March 13, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

February 19, 2018 — A late-breaking analysis of the landmark COMPASS study was presented at the 2018 International ...

Home February 19, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

February 13, 2018 — Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual ...

Home February 13, 2018
Home
News | Pharmaceuticals

February 1, 2018 –Humanetics Corporation (Humanetics) has recently completed two research studies funded by the National ...

Home February 01, 2018
Home
Technology | Antiplatelet and Anticoagulation Therapies

January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of ...

Home January 22, 2018
Home
Subscribe Now